4.4 Article

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis

Judith Eschbach et al.

HUMAN MOLECULAR GENETICS (2013)

Article Biochemistry & Molecular Biology

A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy

Jorge L. Ruas et al.

Review Clinical Neurology

Genetic modifiers of Huntington's disease: beyond CAG

Larissa Arning et al.

FUTURE NEUROLOGY (2012)

Letter Clinical Neurology

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

Michael Orth et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Article Neurosciences

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease

Elahe Taherzadeh-Fard et al.

MOLECULAR NEURODEGENERATION (2011)

Article Neurosciences

Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease

Hong Van B. Che et al.

MOLECULAR NEURODEGENERATION (2011)

Review Pharmacology & Pharmacy

The Role of PGC-1 alpha in the Pathogenesis of Neurodegenerative Disorders

Krisztina Rona-Voeroes et al.

CURRENT DRUG TARGETS (2010)

Review Neurosciences

Sex differences in molecular neuroscience: from fruit flies to humans

Elena Jazin et al.

NATURE REVIEWS NEUROSCIENCE (2010)

Article Cell Biology

PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

Bin Zheng et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Article Neurosciences

The gene coding for PGC-1α modifies age at onset in Huntington's Disease

Patrick Weydt et al.

MOLECULAR NEURODEGENERATION (2009)

Article Neurosciences

PGC-1 alpha as modifier of onset age in Huntington disease

Elahe Taherzadeh-Fard et al.

MOLECULAR NEURODEGENERATION (2009)

Review Pharmacology & Pharmacy

The biology of PGC-1α and its therapeutic potential

Christoph Handschin

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Review Genetics & Heredity

Huntington's disease: the case for genetic modifiers

James F. Gusella et al.

GENOME MEDICINE (2009)

Article Biochemistry & Molecular Biology

Analysis of PGC-1α variants Gly482Ser and Thr612Met concerning their PPARγ2-coactivation function

Inke Nitz et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Clinical Neurology

Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease

C Saft et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)

Article Biochemistry & Molecular Biology

NPS@:: Network Protein Sequence Analysis

C Combet et al.

TRENDS IN BIOCHEMICAL SCIENCES (2000)